Promising Alzheimer’s Test Enters Next Stage of Development

Promising Alzheimer’s Test Enters Next Stage of Development
alzheimer's testAmarantus BioScience Holdings, Inc. recently released promising results from the Lymphocyte Proliferation Test (LymPro Test®) blood diagnostic for Alzheimer's disease (AD) LP-002 study. Amarantus is a biotechnology company focused on research and development of treatments and diagnostics for diseases related to neurodegenerative and apoptosis (programmed cell death) processes that contribute to Alzheimer's disease, Parkinson's disease, and
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *